324 related articles for article (PubMed ID: 30228093)
1. Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice.
Ye J; Huang Y; Que B; Chang C; Liu W; Hu H; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Zhen W; Xu Y; Shi L; Liu J; Jiang H; Ye D; Lin Y; Wan J; Ji Q
EBioMedicine; 2018 Sep; 35():29-39. PubMed ID: 30228093
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice.
Ye J; Que B; Huang Y; Lin Y; Chen J; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Wang Z; Hu H; Xu Y; Shi L; Ye D; Liu J; Jiang H; Wan J; Ji Q
Cardiovasc Res; 2019 May; 115(6):1102-1113. PubMed ID: 30395167
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice.
Ye J; Wang Y; Wang Z; Liu L; Yang Z; Ye D; Wang M; Xu Y; Zhang J; Zhao M; Liu J; Lin Y; Ji Q; Wan J
Aging (Albany NY); 2020 Jan; 12(1):193-203. PubMed ID: 31901899
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice.
Ye J; Wang Y; Xu Y; Wang Z; Liu L; Wang M; Ye D; Zhang J; Yang Z; Lin Y; Ji Q; Wan J
Redox Biol; 2020 Sep; 36():101636. PubMed ID: 32863209
[TBL] [Abstract][Full Text] [Related]
5. Anti-interleukin-5-neutralizing antibody attenuates caradiac injury and cadiac dysfunction by aggravating the inflammatory response in doxorubicin-treated mice.
Xian D; Zhan Y; Yang Z; Fan C; Liu L; Lin Y
Cell Biol Int; 2020 Jun; 44(6):1363-1372. PubMed ID: 32125042
[TBL] [Abstract][Full Text] [Related]
6. IL-27p28 knockout aggravates Doxorubicin-induced cardiotoxicity by regulating Macrophage polarization.
Feng Y; Ji Q; Ye D; Pan H; Lu X; Gan L; Wang M; Liu J; Xu Y; Zhang J; Zhao M; Xu S; Yin Z; Pan W; Wei C; Liu M; Wan J; Ye J
Biochem Pharmacol; 2023 Apr; 210():115469. PubMed ID: 36868324
[TBL] [Abstract][Full Text] [Related]
7. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of IL-12p35 improves cardiac repair after myocardial infarction by promoting angiogenesis.
Kan X; Wu Y; Ma Y; Zhang C; Li P; Wu L; Zhang S; Li Y; Du J
Cardiovasc Res; 2016 Feb; 109(2):249-59. PubMed ID: 26614777
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-9 aggravates doxorubicin-induced cardiotoxicity by promoting inflammation and apoptosis in mice.
Ye D; Wang Z; Xu Y; Ye J; Wang M; Liu J; Zhang J; Zhao M; Chen J; Wan J
Life Sci; 2020 Aug; 255():117844. PubMed ID: 32464124
[TBL] [Abstract][Full Text] [Related]
10. Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice.
Zhang J; Yang Z; Liang Z; Wang M; Hu C; Chang C; Shi L; Ji Q; Liu L
Mediators Inflamm; 2021; 2021():6611085. PubMed ID: 33958974
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress.
Hu J; Wu Q; Wang Z; Hong J; Chen R; Li B; Hu Z; Hu X; Zhang M
Biomed Pharmacother; 2019 Dec; 120():109475. PubMed ID: 31580970
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
13. Trehalose alleviates doxorubicin-induced cardiotoxicity in female Swiss albino mice by suppression of oxidative stress and autophagy.
Abu-Khudir R; Ibrahim WM; Shams ME; Salama AF
J Biochem Mol Toxicol; 2021 Sep; 35(9):e22859. PubMed ID: 34328254
[TBL] [Abstract][Full Text] [Related]
14. LCN2 deficiency ameliorates doxorubicin-induced cardiomyopathy in mice.
Jang HM; Lee JY; An HS; Ahn YJ; Jeong EA; Shin HJ; Kim KE; Lee J; Koh JS; Roh GS
Biochem Biophys Res Commun; 2022 Jan; 588():8-14. PubMed ID: 34933182
[TBL] [Abstract][Full Text] [Related]
15. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TRPA1 Attenuates Doxorubicin-Induced Acute Cardiotoxicity by Suppressing Oxidative Stress, the Inflammatory Response, and Endoplasmic Reticulum Stress.
Wang Z; Wang M; Liu J; Ye J; Jiang H; Xu Y; Ye D; Wan J
Oxid Med Cell Longev; 2018; 2018():5179468. PubMed ID: 29682158
[TBL] [Abstract][Full Text] [Related]
17. Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.
Wang Y; Zhu S; Liu H; Wei W; Tu Y; Chen C; Song J; Li J; Sun S; Wang C; Xu Z
Dis Markers; 2019; 2019():7420196. PubMed ID: 31929843
[TBL] [Abstract][Full Text] [Related]
18. Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction.
Miyata M; Suzuki S; Misaka T; Shishido T; Saitoh S; Ishigami A; Kubota I; Takeishi Y
PLoS One; 2013; 8(12):e79093. PubMed ID: 24391705
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12p35 Deficiency Reverses the Th1/Th2 Imbalance, Aggravates the Th17/Treg Imbalance, and Ameliorates Atherosclerosis in ApoE-/- Mice.
Huang Y; Hu H; Liu L; Ye J; Wang Z; Que B; Liu W; Shi Y; Zeng T; Shi L; Ji Q; Chang C; Lin Y
Mediators Inflamm; 2019; 2019():3152040. PubMed ID: 31093011
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice.
Zhang Y; Kang YM; Tian C; Zeng Y; Jia LX; Ma X; Du J; Li HH
PLoS One; 2011; 6(6):e21104. PubMed ID: 21738612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
